Diaphoresis is an uncommon presenting symptom in children. We present a 4 year old boy, with a history of increased sweating of 2 years duration. Review of systems was negative for diarrhea, flushing, or abdominal pain. On exam, the child had normal blood pressure and heart rate. An abdominal mass could not be appreciated. Laboratory studies were significant for modestly elevated serum, and urinary dopamine and norepinephrine levels. Computerized tomography scan showed a 31 Â 39 Â 51 mm pelvic mass. The patient underwent laparoscopic resection of the mass. After resection, catecholamine levels normalized, and sweating stopped. Pathologic evaluation of the surgical specimen revealed a maturing ganglioneuroma (GN). Health-care providers might easily overlook excessive sweating in a child, which can be a presenting symptom of catecholamine-secreting tumors.
Sweating, in normal physiologic conditions, is mediated both by cholinergic and adrenergic stimulation. Excessive sweating, or diaphoresis, may be caused by the beta-adrenergic effects of circulating ectopic catecholamines, produced by functional tumors, of which pheochromocytoma and paraganglioma are the most common. Diaphoresis as a clinical indicator of an underlying disease has been infrequently reported in pediatric age group, especially the very young, and might be overlooked by pediatric healthcare providers.
Ganglioneuromas (GNs) are benign tumors that originate from neural crest cells, which form the sympathetic nervous system. They are composed mainly of mature ganglion cells. The International Neuroblastoma Pathology Committee (INPC) define GNs as a schwannian stroma-dominant tumor, predominantly composed of ganglioneuromatous stroma, with a minor component of scattered collections of differentiating neuroblasts, and/or maturing or mature ganglion cells [1] .
GNs can either develop de-novo, or as a result of spontaneous or chemotherapy induced maturation of a less mature neuroblastic tumor, such as neuroblastoma or ganglioneuroblastoma [2] . GNs may develop anywhere along the sympathetic nerve chain, most common locations in descending order of frequency are posterior mediastinum, retroperitoneum, adrenal gland, neck, and pelvis. Functional GNs are relatively rare in children.
Case report
4 year, 2 month old, otherwise healthy boy, presented to our care because of a history of copious sweating of 2 years duration over his entire body. His mother noted a significant increase in the severity of sweating, over the past 3e4 months, occurring mostly at night. History was negative for seizures, fever, diarrhea, loose stools, flushing, chest pain, tremors, abdominal pain, headaches, or visual changes. On physical exam, no abnormalities were detected. Blood pressure and heart rate readings, for the last three clinic visits were reviewed, and were always in the normal range. Initial laboratory evaluation was unremarkable.
The child was referred to pediatric endocrinology clinic. Thyroid function tests and serum electrolytes were all in the normal range. However, plasma dopamine and norepinephrine levels were found to be elevated. Urinary normetanephrine to creatinine, norepinephrine to creatinine, and dopamine to creatinine ratios were also elevated. Table 1 summarizes the pre-operative and post-operative (48 days after surgery) catecholamine values, in plasma and urine.
Surgical consultation was obtained and a computerized tomography scan of the chest, abdomen and pelvis, with intravenous and oral contrast, was performed (Fig. 1) . The study demonstrated a pelvic soft tissue mass measuring 31 Â 39 Â 51 mm. It was rounded, with some irregular enhancing areas, and multiple speckled calcifications were present, with no evidence of bony erosion, or invasion. The adrenal glands and kidneys appeared normal, with no evidence of metastatic disease. Metaiodobenzylguanidine (MIBG) scan was done and interestingly showed no uptake in the pelvic mass.
The child was pretreated with an alpha-blocking agent, Phenoxybenzamine 10 mg, given daily orally. The drug was provided initially as an inpatient and subsequently at home, to complete one week of treatment prior to surgery. A beta blocking agent, atenolol 1 mg/kg given daily orally, was added for 48 h before surgery. Both drugs were well tolerated, with no recorded hypotension or bradycardia. Laparoscopic resection of the pelvic tumor was then performed. The mass was situated at the aortic bifurcation deriving most of its blood supply from the sacral artery and branches of the internal iliac artery. The dissection plane was developed on the adventitia of the aorta, common iliac arteries and internal iliac arteries. The iliac veins were also intimately associated with the mass. However the adventitial plane remained free of tumor. Normal and stable vital signs were maintained with tumor manipulation, and blood pressure support was not required intra-operatively. The mass was extracted through a slightly enlarged umbilical incision. After surgery, patient had an uneventful recovery, started a regular diet on the first day after surgery. Pain was well controlled. He received intravenous morphine for one day (two doses of 0.05 mg/ kg), and oral acetaminophen (15 mg/kg every 6 h) for three days. He was discharged home on the third post-operative day. His symptoms of sweating resolved completely after surgery. Pathological evaluation of the surgical specimen showed maturing ganglioneuroma with no evidence of malignancy (Fig. 2) . The boy remains asymptomatic, without evidence of recurrent disease.
Discussion
Functional adrenergic tumors in general are uncommon in the pediatric population. Adrenergic tumors presenting with diaphoresis are reported infrequently, possibly because complaints of excessive sweating may be difficult to elicit from young children. To our knowledge, this is the first report of a child presenting with diaphoresis resulting from a functional GN. In another reported case, a 4 month old girl with 3.5 cm right paraspinal neuroblastoma, who initially presented with an abdominal mass and resting tachycardia and hypertension, was retrospectively discovered to have had a history of excessive sweating with feeding [3] .
GNs are most commonly clinically silent, and are often discovered incidentally on imaging studies [4] . Because they may not produce symptoms, GNs may not be discovered until they are very large and compress nearby structures. In contrast, patients with GNs that secrete catecholamines or their metabolites may present with labile hypertension, diarrhea, flushing, diaphoresis, or palpitation [5] . The proportion of patients with GNs, that secrete catecholamines, and are symptomatic, is not known.
Diagnosis may be suspected when excessive levels of catecholamines and their metabolites are detected in serum, or urine of patients. Axial and functional imaging such as computerized tomography (CT) scan, magnetic resonance imaging (MRI), and 123I-or 131I-labeled metaiodobenzylguanidine (MIBG) scintigraphy are helpful tools for assessment and localization of the tumor [6] . CT images may show a homogenous, low attenuation mass containing discrete and punctate calcifications in 20% of the cases. Typically, slight or inhomogeneous enhancement is reported on delayed scans. MRI demonstrates lesions that are relatively homogenous, with low signal intensity on T1 weighted images, and intermediate to high signal intensity on T2 weighted images [7] . MIBG may be useful for functional tumors. A retrospective analysis of 49 patients with GNs, demonstrated an increase in the catecholamine levels in 39% of the patients, and MIBG uptake was seen in 57% of the patients [4] . We did not obtain an MRI, as CT findings were sufficient to delineate the child's anatomy. Our patient's tumor was not demonstrated by MIBG scintigraphy despite secreting catecholamines. Tissue analysis is required for definitive diagnosis of GNs, since neither signs, symptoms, nor imaging studies reliably differentiate benign GNs from malignancies such as neuroblastoma or pheochromocytoma. We feel that percutaneous biopsy is insufficient for the diagnosis of GNs in childhood, because neuroblastic elements can be sporadically dispersed within the tumor. A retrospective review of pathological specimens of 76 GNs in the Italian collaborative study permitted to reclassify one third of them as ganglioneuroblastoma intermixed [8] . In addition, malignant transformation of GN into neuroblastoma, albeit rare, has been reported in the literature [9, 10] . Histological evaluation of resected specimen is usually sufficient to make the pathological diagnosis. Immunohistochemistry is used when histological findings are indeterminate for GN or mixed with elements of pheochromocytoma [11, 12] .
GNs are not responsive to chemotherapy, and complete surgical resection is usually curative, with excellent postoperative prognosis [13] . We feel that surgical resection is required in all patients, without sacrificing essential structures.
Surgical resection can be challenging however. GNs can be very large, densely adherent or encase adjacent major vascular structures. One should aim at complete removal of the tumor. In certain cases, incomplete resection is an acceptable alternative, given the good prognosis of these lesions [14] . In a recent Italian co-operative neuroblastoma group retrospective analysis of 146 children under 18 years old, treated over a 27-year period, surgery was associated with significant risk of complications. Two patients died of bleeding after surgery, eight developed serious complications, and another 17 suffered moderate, but sometimes permanent complications. Overall, the surgery-related complication rate was 17.8%. In addition, three patients underwent nephrectomy in the course of tumor resection. The authors in this study concluded that cautious surgical approach should be recommended for childhood GNs [8] . In the current study we performed the resection laparoscopically.
Laparoscopic resection of pelvic and abdominal retroperitoneal tumors is feasible and can be done safely, even when tumors secrete catecholamines, with low rate of significant blood loss, complications, and conversion [5] .
There are currently no specific recommendations for preoperative alpha adrenergic blockade for GNs presenting with diaphoresis. In the Italian co-operative neuroblastoma group study, there was no report of any surgery complicated by hypertensive crisis [8] . Unlike pheochromocytoma, GNs are less likely to be metabolically active. However, in cases of catecholamines-secreting GNs, there is a potential that excess amounts of catecholamine might be released during the manipulation of the tumor, such an occurrence can result in catecholamine surge, leading to intra-operative hemodynamic instability. We feel that in patients with neurogenic tumors, which are shown to be catecholamine secreting, preoperative alpha-adrenergic blockade is necessary and may facilitate safer surgical excision. Hypertensive spells upon tumor manipulation have been reported during resection of metabolically active GNs [15] . We elected to proceed with alpha and beta adrenergic blockade in our patient. This was well tolerated well and we believe contributed to a smoother perioperative course.
Conclusion
GNs are rare, benign tumors, usually nonfunctional and asymptomatic, however a proportion of GNs might be hormonally active. Prolonged and unexplained diaphoresis in a child warrants screening urine and serum for catecholamine overproduction. The pre-operative utilization of alpha blockade is not recommended in non-functional GNs. However in symptomatic, hormonally active tumors, pre-operative alpha blockade might be indicated and can be safely performed.
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